Change search
ReferencesLink to record
Permanent link

Direct link
The use of melatonin in Swedish children and adolescents-a register-based study according to age, gender, and medication of ADHD
Karlstad University, Faculty of Health, Science and Technology (starting 2013), Department of Health Sciences. Karlstad University, Faculty of Technology and Science, Department of Chemistry and Biomedical Sciences.
Department of Psychiatry, County Council of Värmland, Värmland, Sweden; Child and Adolescent Psychiatry, Central Hospital, S-651 85, Karlstad, Sweden .
2015 (English)In: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 71, no 7, 877-881 p.Article in journal (Refereed) Published
Abstract [en]

The use of melatonin is increasing among Swedish children and adolescents despite deficient knowledge of usage in these groups. The aim of this study was to investigate the use of melatonin in Swedish children and adolescents according to age, gender, dosage, treatment duration, and use of attention deficit hyperactivity disorder (ADHD) medication. Data from the Swedish Prescribed Drug Register was analyzed for children and adolescents 0-19 years old in Sweden during 2006-2013. The number of new users of melatonin in 2013 was 4296 and 3093 among boys and girls, respectively. Girls started treatment with melatonin in older ages compared to boys. Regular users of melatonin were most common among boys 10-14 years. The average defined daily dose (DDD) per regular user was decreasing from 2.4 DDD in 2006 to 1.7 DDD in 2012. Among girls and boys 5-9 years who were regular users in 2010, over 40 and 50 %, respectively, were still regular users in 2013. In the age group 15-19 years, only about 10 % were still regular users in 2013. In 2013, 65 % of boys and 49 % of girls, using melatonin regularly, also used medication for ADHD regularly. More Swedish boys than girls used melatonin regularly. The boys started treatment earlier and more often combined regular use of melatonin with regular use of medication for ADHD. This indicates that girls and boys partly are prescribed melatonin for different reasons. About half of the younger children stayed on melatonin treatment for several years, while 90 % of adolescents (15-19 years) concluded their treatment.

Place, publisher, year, edition, pages
Springer Berlin/Heidelberg, 2015. Vol. 71, no 7, 877-881 p.
Keyword [en]
melatonin, ADHD, Swedish children, Swedish adolescents, gender, medication
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Research subject
Public Health Science
Identifiers
URN: urn:nbn:se:kau:diva-37301DOI: 10.1007/s00228-015-1866-3ISI: 000356047800010PubMedID: 25995170OAI: oai:DiVA.org:kau-37301DiVA: diva2:844502
Available from: 2015-08-06 Created: 2015-08-06 Last updated: 2016-04-13Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Health SciencesDepartment of Chemistry and Biomedical Sciences
In the same journal
European Journal of Clinical Pharmacology
Public Health, Global Health, Social Medicine and Epidemiology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 17 hits
ReferencesLink to record
Permanent link

Direct link